| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/03/2013 | CN103025339A Expression modulator for clock gene Period |
| 04/03/2013 | CN103012407A N-[4-(1H-pyrazolo[3,4-b]pyrazine-6-yl)-phenyl]-sulfonamides and application of N-[4-(1H-pyrazolo[3,4-b]pyrazine-6-yl)-phenyl]-sulfonamides as medicines |
| 04/03/2013 | CN103012390A Indole derivatives as S1P1 receptor |
| 04/03/2013 | CN103012254A Pyridone derivatives for modulating stress-activated protein kinase system |
| 04/03/2013 | CN103007197A Oral traditional Chinese medicine liquid for restoring yang |
| 04/03/2013 | CN103007186A Chinese medicinal formulae used for treating increase of jaundice |
| 04/03/2013 | CN103007154A Traditional Chinese medicine scented sachet for relieving spring drowsiness |
| 04/03/2013 | CN103007069A Method for treating night sweat by using bligted wheat |
| 04/03/2013 | CN103006982A Medicinal composition for treating thyromegaly |
| 04/03/2013 | CN103006974A Formula of children hyperhidrosis treatment traditional Chinese medicine |
| 04/03/2013 | CN103006945A Multifunctional medicinal liquor for external use |
| 04/03/2013 | CN103006824A Method for extracting tritepenoidic acid from jujube leaves |
| 04/03/2013 | CN103006735A Traditional Chinese medicine scented sachet for relieving spring drowsiness |
| 04/03/2013 | CN102302736B Traditional Chinese medicine for treating lipoma disease |
| 04/03/2013 | CN102188658B Chinese medicine preparation for treating essence and blood deficiency for kidney-yin deficiency patients, preparation method thereof and application thereof |
| 04/03/2013 | CN102174097B Actinoporin and application thereof |
| 04/03/2013 | CN102127054B 3-(substituted dihydroisoindol-2-yl)-2,6-piperidinedione polymorph and pharmaceutical composite |
| 04/03/2013 | CN102086182B Petasites tatewakianus Kitam. extract as well as preparation method and application thereof |
| 04/03/2013 | CN101921225B Pirfenidone compound, preparation method and application thereof |
| 04/03/2013 | CN101801414B Oral and skin compositions |
| 04/03/2013 | CN101711162B Processed product of fenugreek seed, and method for production thereof |
| 04/03/2013 | CN101489984B Aminoindan derivative or salt thereof |
| 04/03/2013 | CN101228172B 6,7-unsaturated-7-carbamoyl substituted morphinan derivative |
| 04/02/2013 | US8410266 2,4-pyrimidinediamine compounds and their uses |
| 04/02/2013 | US8410174 Method for treating arthritis |
| 04/02/2013 | US8410148 Method and composition for potentiating an opiate analgesic |
| 04/02/2013 | US8410110 9-(piperazinylalkyl) carbazoles as Bax-modulators |
| 04/02/2013 | US8410101 Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease |
| 04/02/2013 | US8410061 Variants of hedgehog protein that contain N-terminal modifications are described that can block hedgehog function; thus allowing these variants to serve as functional antagonists. These peptides have a primary amino acid sequence |
| 04/02/2013 | US8410059 CXCR4 antagonist and use thereof |
| 04/02/2013 | US8410057 Method of inducing T cell apoptosis by administering Altered Peptide Ligand |
| 04/02/2013 | US8410056 Pro-oxidant anti-cancer compounds |
| 04/02/2013 | US8410055 Skin wound healing compositions and methods of use thereof |
| 04/02/2013 | US8410053 Methods for treating autoimmune disorders, and reagents related thereto |
| 04/02/2013 | CA2715143C Novel phenylpyrrole derivative |
| 04/02/2013 | CA2585642C Carbazole derivatives, solvates thereof, or pharmaceutically acceptable salts thereof |
| 04/02/2013 | CA2502948C Modified bio-related substance, process for producing the same, and intermediate |
| 04/02/2013 | CA2472647C Mammal prolactin variants |
| 04/02/2013 | CA2470920C Liposomal delivery of vitamin e based compounds |
| 04/02/2013 | CA2457611C Novel molecular target for neurotoxicity |
| 04/02/2013 | CA2396212C Recombinant antibodies to human interleukin-1 beta |
| 03/28/2013 | WO2013043085A1 Pharmaceutical substance (variants) and compositions based thereon which exhibit modulatory activity with a commensurate effect |
| 03/28/2013 | WO2013042782A1 Condensed heterocyclic compound |
| 03/28/2013 | WO2013041696A1 Stimulating and invigorating nasal spray and nasal drop |
| 03/28/2013 | WO2013041090A1 Use of klinoptilolith or klinoptilolith-containing mixtures for producing medicinal products |
| 03/28/2013 | WO2013016720A3 Novel substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases |
| 03/28/2013 | WO2012061395A3 Cytotoxic agents against cancer cells and uses thereof |
| 03/28/2013 | US20130079767 Embolization |
| 03/28/2013 | US20130079514 "omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells" |
| 03/28/2013 | US20130079391 Lipase inhibiting composition |
| 03/28/2013 | US20130079387 Antisense oligonucleotide modulation of raf gene expression |
| 03/28/2013 | US20130079351 2-acylaminothiazole derivative or salt thereof |
| 03/28/2013 | US20130079332 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 03/28/2013 | US20130078266 Immunosuppression By Blocking T Cell Co-Stimulation Signal 2 (B7/CD28 Interaction) |
| 03/28/2013 | US20130078220 Dopaminergic neuronal survival-promoting factors and uses thereof |
| 03/28/2013 | CA2849711A1 Compound having modulatory activity with a commensurate effect, pharmaceutical substance (variants), application of pharmaceutical substance, pharmaceutical and parapharmaceuticalformulation (variants), method of preparation of pharmaceutical compositions |
| 03/27/2013 | EP2573081A1 Prophylactic and/or therapeutic agent for non-alcoholic steatohepatitis |
| 03/27/2013 | EP2573078A1 Acrylamide compounds and use thereof for inhibiting apoptosis |
| 03/27/2013 | EP2572717A1 Pharmaceutical composition containing solifenacin |
| 03/27/2013 | EP2572711A1 Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient |
| 03/27/2013 | EP2572710A2 Novel use of panduratin derivatives or an extract of boesenbergia pandurata for promoting muscle mass growth, fighting fatigue, and enhancing exercise performance capability |
| 03/27/2013 | EP2571500A1 Treatment for altitudinal hypoxia |
| 03/27/2013 | CN1972916B 肉桂酰胺类化合物 Cinnamic amides |
| 03/27/2013 | CN103003282A A process for the preparation of novel porphyrin derivatives and their use as PDT agents and fluorescence probes |
| 03/27/2013 | CN103003262A Nitrogenated aromatic heterocyclic ring derivative |
| 03/27/2013 | CN103003234A N-hydroxyformamide derivative and pharmaceutical containing same |
| 03/27/2013 | CN103003233A Novel hydroxamic acid derivative |
| 03/27/2013 | CN103002923A Stabilized fibronectin domain compositions, methods and uses |
| 03/27/2013 | CN103002893A Therapeutic agent or prophylactic agent for neuropathic pain |
| 03/27/2013 | CN103002889A Sn-2-monoacylglycerols and lipid malabsorption |
| 03/27/2013 | CN102994508A Olmsted syndrome related gene identification, identification product, identification method, and use of identification |
| 03/27/2013 | CN102993195A Substitutional-2-(chroman-6-oxyl) thiazole and application thereof as medicine |
| 03/27/2013 | CN102993084A Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 03/27/2013 | CN102988995A Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from HIV-TAT |
| 03/27/2013 | CN102988985A Use of miR-146a as blood vessel growth regulation target |
| 03/27/2013 | CN102988957A Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 03/27/2013 | CN102988951A Medicine for treating children with congestive splenomegaly |
| 03/27/2013 | CN102988880A Product capable of repairing disease-causing gene and prepared from Chinese herbal medicine and edible medical fungi and method |
| 03/27/2013 | CN102988790A Akebiaquinata tablets for clearing away heart-fire |
| 03/27/2013 | CN102988722A American ginseng tablets for boosting qi and nourishing yin |
| 03/27/2013 | CN102988721A Chinese medicinal composition with function of inducing diuresis for treating strangurtia, and preparation method thereof |
| 03/27/2013 | CN102988554A Foot therapy massage cream |
| 03/27/2013 | CN102988417A Use of parasitic biological agents for diseases prevention and control |
| 03/27/2013 | CN102988397A Application of Houttuynoid A for preparing monoamine oxidase (MAO) inhibitor medicine |
| 03/27/2013 | CN102988396A Application of Houttuynoid D in preparation of monoamine oxidase (MAO) inhibitor |
| 03/27/2013 | CN102228644B Medicament for treating thyrocele and preparation method thereof |
| 03/27/2013 | CN102206247B Novel peptides as NS3/NS4a serine protease inhibitors of hepatitis C virus |
| 03/27/2013 | CN102199197B Polypeptides with function of self-assembled potassium channel and its application |
| 03/27/2013 | CN102105154B Preparation for oral administration comprising water-extracted chondroitin sulfate and quercetin glycoside |
| 03/27/2013 | CN102030818B Peptide inhibiting angiontensin converting enzyme |
| 03/27/2013 | CN101921772B Human antibodies that bind human IL-12 and methods for producing |
| 03/27/2013 | CN101906464B Proteins producing an altered immunogenic response and methods of making and using the same |
| 03/27/2013 | CN101808651B Polymer conjugate of steroid |
| 03/27/2013 | CN101747327B Aromatic amide thiazole derivative, preparation method and application thereof |
| 03/27/2013 | CN101605817B Cellulose derivative and method for production thereof |
| 03/27/2013 | CN101243056B Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 03/27/2013 | CN101066997B Human antibodies that bind human IL-12 and methods for producing |
| 03/26/2013 | US8404805 Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 03/26/2013 | US8404802 a targeting vector which binds to receptors associated with integrin receptors, angiogenesis; contrast agents; diagnosis of malignant diseases, heart diseases, inflammation-related diseases, rheumatoid arthritis and Kaposi's sarcoma |
| 03/26/2013 | US8404793 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |